Canal Capital Management, LLC

Position in GSK — GSK plc

CIK 1666733 Richmond, VA

Position in GSK

as of Jun 30, 2026 · filed Jul 28, 2026 Compact

Position Value

$356,456

-$18,836 QoQ

Shares Held

6,800

0.0% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.06%

of 13F equity value

Holder Rank

#551

of 1,032 holders

Holding Since

Sep 2022

16 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Canal Capital Management, LLC holds $33,454,879 across 10 Drug Manufacturers - General names. GSK ranks #7 (1.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson	46,715	$11,864,208
2	LLY	ELI LILLY & Co	7,938	$9,521,076
3	AMGN	Amgen Inc	24,312	$8,803,861
4	ABBV	AbbVie Inc.	4,890	$1,230,519
5	NVS	Novartis AG	2,906	$455,428
6	AZN	Astrazeneca PLC	1,927	$365,397
7	GSK	GSK plc This page	6,800	$356,456
8	NVO	Novo Nordisk A S	6,524	$312,760

16 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$356,456	6,800	0.0%	Shares	Sole	2026-07-28
2026-03-31	$375,292	6,800	0.0%	Shares	Sole	2026-04-27
2025-12-31	$333,472	6,800	0.0%	Shares	Sole	2026-01-06
2025-09-30	$293,488	6,800	-19.1%	Shares	Sole	2026-01-06
2025-06-30	$322,944	8,410	0.0%	Shares	Sole	2025-09-19
2025-03-31	$325,803	8,410	-2.6%	Shares	Sole	2025-09-19
2024-12-31	$292,137	8,638	-41.3%	Shares	Sole	2025-02-14
2024-09-30	$601,140	14,705	+0.9%	Shares	Sole	2024-10-23
2024-06-30	$561,060	14,573	0.0%	Shares	Sole	2024-07-30
2024-03-31	$624,744	14,573	-2.7%	Shares	Sole	2024-04-23
2023-12-31	$555,010	14,976	-3.4%	Shares	Sole	2024-01-24
2023-09-30	$562,201	15,509	+3.8%	Shares	Sole	2023-10-25
2023-06-30	$532,532	14,942	0.0%	Shares	Sole	2023-07-26
2023-03-31	$531,636	14,942	-3.3%	Shares	Sole	2023-05-04
2022-12-31	$543,194	15,458	+7.2%	Shares	Sole	2023-02-13
2022-09-30	$424,321	14,418	—	Shares	Sole	2022-10-24
No filing history on record for this holder in this stock.